> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CDER Compliance Director Schnedar Resigns
- URL: https://www.fdaweb.com/cder-compliance-director-schnedar-resigns/
- Published: 2016-03-31T12:00:00.000Z
- Updated: 2026-09-14T20:52:10.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5135243

> CDER Office of Compliance (OC) director **Cynthia Schnedar** has resigned and Office of Manufacturing Quality director **Tom Cosgrove** will assume the OC director role in an acting capacity on 4/4\. Schnedar’s departure comes three months after she was recused from working on substantive issues relating to compliance actions and policy because her husband, **Mark Polston**, had been named an equity partner at King and Spalding ([see earlier story](http://fdaweb.com/login.php?sa=v&aid=D5134341&searchWords=office%20of%20compliance&cate=S&stid=%241%248J4.vm3.%24jVVFmFCEBaR07icwj0Uje%2F&ref=fdaweb.com)).